Get the Stockscreener App
13.60
3.27%
-0.46
After Hours:
13.66
0.06
+0.44%
Carlsmed Inc stock is traded at $13.60, with a volume of 153.83K.
It is down -3.27% in the last 24 hours and up +0.00% over the past month.
Carlsmed Inc is a commercial-stage medical technology company pioneering AI-enabled personalized spine surgery solutions with a mission to improve outcomes and decrease the cost of healthcare for spine surgery and beyond. It is focused on becoming the standard of care for spine fusion surgery. The aprevo Technology Platform consists of AI-enabled software solutions, and interbody implants that it custom design for each patient's unique pathology and vertebral bone topography, and single-use surgical instruments. The Company designs, manufactures, and markets aprevo, a comprehensive technology platform for spine fusion surgery procedures.
See More
Previous Close:
$14.06
Open:
$13.81
24h Volume:
153.83K
Relative Volume:
5.59
Market Cap:
$360.62M
Revenue:
-
Net Income/Loss:
-
P/E Ratio:
-
EPS:
-
Net Cash Flow:
-
1W Performance:
-6.21%
1M Performance:
+0.00%
6M Performance:
+0.00%
1Y Performance:
+0.00%
1-Day Range:
$13.56
$13.83
1-Week Range:
$13.56
$15.10
52-Week Range:
$13.56
$15.10
Carlsmed Inc Stock (CARL) Company Profile
Name
Carlsmed Inc
Sector
Industry
Phone
-
Address
-
Compare CARL with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CARL
Carlsmed Inc
|
13.60 | 372.82M | 0 | 0 | 0 | 0.00 |
|
VEEV
Veeva Systems Inc
|
281.35 | 46.44B | 2.86B | 780.66M | 1.20B | 4.72 |
|
TEM
Tempus Ai Inc
|
54.89 | 9.80B | 803.32M | -709.10M | -212.68M | -7.8003 |
|
HQY
Healthequity Inc
|
91.06 | 8.39B | 1.15B | 96.70M | -161.99M | 1.09 |
|
DOCS
Doximity Inc
|
57.33 | 11.01B | 550.17M | 201.35M | 232.07M | 1.00 |
|
WAY
Waystar Holding Corp
|
35.59 | 6.44B | 906.14M | -52.62M | 89.62M | -0.3621 |
Carlsmed Inc Stock (CARL) Latest News
Carlsmed’s aprevo® Personalized Interbody Implants Receive CMS New Technology Add-On Payment (NTAP) for Cervical Fusion Procedures - Ortho Spine News
Carlsmed’s aprevo implants receive CMS NTAP for cervical fusion procedures - TipRanks
AI medtech firm Carlsmed prices $100.5M IPO - MSN
Medtech IPOs Spur Talk of Broader US Health-Care Listing Revival - Bloomberg
Carlsmed's Aprevo Powers First Personalized Cervical Spine Surgery - MarketScreener
Carlsmed announces completion of first aprevo cervical procedure - TipRanks
Carlsmed’s aprevo® Powers First Personalized Cervical Spine Surgery - Ortho Spine News
Carlsmed’s Nasdaq Debut Gets $100.5M - San Diego Business Journal
Carlsmed Launches $100.5 Million Initial Public Offering - Global Legal Chronicle
Carlsbad-based medical technology company begins trading on Nasdaq - MSN
Latham & Watkins Advises on Carlsmed, Inc.’s US$100.5 Million Initial Public Offering - Latham & Watkins LLP
Carlsmed Insider Bought Shares Worth $899,985, According to a Recent SEC Filing - MarketScreener
Carlsmed director Philip Young buys $900k in shares By Investing.com - Investing.com Canada
Carlsmed (CARL) director Sidow buys $199,995 in shares - Investing.com Australia
Carlsmed (CARL) director Sidow buys $199,995 in shares By Investing.com - Investing.com Canada
Carlsmed director Philip Young buys $900k in shares - Investing.com
Carlsmed director Mittendorff buys $20 million in shares By Investing.com - Investing.com India
Carlsmed director Mittendorff buys $20 million in shares - Investing.com
Carlsmed, Inc. Completes Initial Public Offering - TipRanks
Carlsmed 6.7M share IPO priced at $15 per share - MSN
Carlsmed: Redefining Precision And Personalization In Spine Surgery With AI-Powered Aprevo - RTTNews
Carlsmed, Inc.(NasdaqGS: CARL) added to NASDAQ Composite Index - MarketScreener
Carlsmed: Spine Play Does Not Have My Backing Yet (NASDAQ:CARL) - Seeking Alpha
Carlsmed times IPO with reimbursement boon - Axios
Carlsmed Inc. (CARL): MedTech Makes Uninspiring Debut, Opens Flat and Trades Below Issue - Smartkarma
AI Spine Surgery Firm Carlsmed Shares Fall 3.3% After IPO - Bloomberg
Carlsmed begins trading on Nasdaq at $15 per share - Investing.com
Carlsmed (CARL): Assessing the Post-IPO Dip in a High-Growth MedTech Disruptor - AInvest
Carlsmed begins trading on Nasdaq at $15 per share By Investing.com - Investing.com Canada
Carlsmed, Inc Rings the Nasdaq Stock Market Opening Bell - Nasdaq
Carlsmed, Inc Rings the Opening Bell - Nasdaq
Carlsmed Prices $100.5 Million IPO - MarketScreener
Carlsmed's $100.5M IPO: A Strategic Play in AI-Driven Personalized Spine Surgery - AInvest
Carlsmed Sets IPO Price at $15 per Share to Raise $100.5M - AInvest
Carlsmed raises USD 100.5M through IPO - Medical Buyer
Carlsmed launches IPO of 6.7 million shares priced $14-16 each - Investing.com Australia
Carlsmed prices IPO at $15 per share, to begin trading today - Investing.com Australia
Carlsmed's AI-Driven Spine Surgery Innovation and IPO Valuation: A Strategic Buy Opportunity for Long-Term Growth - AInvest
Carlsmed prices IPO at $15 per share, raising $100.5 million By Investing.com - Investing.com India
Carlsmed's AI-Driven Spine Surgery Platform and Its IPO Implications - AInvest
Carlsmed Inc Stock (CARL) Financials Data
There is no financial data for Carlsmed Inc (CARL). Check out other stocks for more information.
Revenue
Net Income
Cash Flow
EPS
Carlsmed Inc Stock (CARL) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Sidow Kevin | Director |
Jul 24 '25 |
Buy |
15.00 |
13,333 |
199,995 |
59,566 |
| Mittendorff Robert II | Director |
Jul 24 '25 |
Buy |
15.00 |
1,333,333 |
19,999,995 |
5,013,839 |
| ROOT JONATHAN D | Director |
Jul 24 '25 |
Buy |
15.00 |
466,666 |
6,999,990 |
483,999 |
| YOUNG PHILIP M | Director |
Jul 24 '25 |
Buy |
15.00 |
59,999 |
899,985 |
53,333 |
0.98%
0.00%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):